|
End-of-day quote
Korea S.E.
2026-09-29
|
5-day change | 1st Jan Change | ||
| 1,864.00 KRW | +0.43% |
|
-1.06% | -62.72% |
| Market Cap | 28.2B 20.79M 18.35M 17.36M 15.74M 29.52M 2B 29.81M 208M 80.26M 1.02B 78.07M 76.37M 3.28B | P/E 2024 |
-2.12x | P/E 2025 | -9.5x |
|---|---|---|---|---|---|
| Enterprise Value | 11.01B 8.12M 7.16M 6.78M 6.15M 11.52M 779M 11.63M 81.29M 31.33M 398M 30.47M 29.81M 1.28B | EV / Sales 2024 |
4.85x | EV / Sales 2025 | 3.87x |
| Free-Float |
41.27% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.43% | ||
| 1 week | -1.06% | ||
| Current month | +0.22% | ||
| 1 month | -0.59% | ||
| 3 months | +6.45% | ||
| 6 months | -44.85% | ||
| Current year | -62.72% |
| 1 week | 1,839 |  | 1,900 |
| 1 month | 1,717 | | 2,005 |
| Current year | 1,430 | | 5,400 |
| 1 year | 1,430 | | 6,660 |
| 3 years | 1,430 | | 27,680 |
| 5 years | 1,430 | | 80,600 |
| 10 years | 1,430 | | 426,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jung-Chool Kim
CEO | Chief Executive Officer | 70 | 2022-03-22 |
Young-Suk Yeom
AUD | Comptroller/Controller/Auditor | 51 | - |
Jong-Su Kang
SAM | Sales & Marketing | 62 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Soon-Kyu Park
BRD | Director/Board Member | 59 | - |
Jung-Chool Kim
BRD | Director/Board Member | 70 | 2022-03-22 |
Jae-Seob Kim
BRD | Director/Board Member | 63 | 2017-01-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | -1.06% | -71.84% | -92.47% | 20.63M | |
| -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | |
| -1.61% | -0.60% | +47.32% | +71.79% | 655B | |
| -1.12% | -0.72% | +17.98% | +76.63% | 471B | |
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | |
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | |
| -0.51% | -1.93% | +12.09% | +11.94% | 257B | |
| +1.32% | +3.27% | +54.63% | +57.63% | 226B | |
| -0.61% | -0.91% | +34.33% | +101.87% | 189B | |
| -0.24% | -2.76% | -28.41% | -60.92% | 170B | |
| Average | -0.13% | +0.13% | +18.76% | +35.53% | 364.29B | |
| Weighted average by Cap. | -0.05% | +0.42% | +38.91% | +70.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.4B 12.09M 10.67M 10.1M 9.16M 17.17M 1.16B 17.34M 121M 46.68M 592M 45.4M 44.42M 1.91B | 9.81B 7.23M 6.38M 6.04M 5.48M 10.27M 694M 10.37M 72.43M 27.92M 354M 27.15M 26.56M 1.14B |
| Net income | -28.09B -20.71M -18.28M -17.3M -15.69M -29.41M -1.99B -29.7M -207M -79.96M -1.01B -77.78M -76.09M -3.27B | -5.56B -4.1M -3.62M -3.42M -3.1M -5.82M -393M -5.88M -41.06M -15.82M -201M -15.39M -15.06M -646M |
| Net Debt | -25.07B -18.48M -16.31M -15.43M -14M -26.24M -1.77B -26.5M -185M -71.35M -906M -69.4M -67.89M -2.91B | -17.19B -12.68M -11.19M -10.58M -9.6M -18M -1.22B -18.17M -127M -48.94M -621M -47.6M -46.56M -2B |
Employees
11
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | ₩1,864.00 | +0.43% | 660 |
| 26-09-28 | ₩1,856.00 | +0.11% | 2,718 |
| 26-09-23 | ₩1,854.00 | -1.59% | 1,130 |
| 26-09-22 | ₩1,884.00 | +1.56% | 859 |
- Stock Market
- Stocks
- A109960 Stock
Select your edition
All financial news and data tailored to specific country editions
